Pramlintide Acetate Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2025-10-27 · last update 2025-10-27
Manufacturers: AstraZeneca AB
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02) | AstraZeneca AB | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted 10/27/2025 Updated 10/27/2025 Discontinued 10/27/2025 |
| SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02) | AstraZeneca AB | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted 10/27/2025 Updated 10/27/2025 Discontinued 10/27/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)